Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in (Q57243499)

From Wikidata
Jump to navigation Jump to search
scholarly article by Kim Fox et al published November 2006 in American Heart Journal
edit
Language Label Description Also known as
English
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in
scholarly article by Kim Fox et al published November 2006 in American Heart Journal

    Statements

    Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in (English)
    0 references
    0 references
    0 references
    Kim Fox
    0 references
    Roberto Ferrari
    0 references
    Ian Ford
    0 references
    November 2006
    0 references
    152
    0 references
    5
    0 references
    860-866
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit